dc.contributor.author | Celikoyar, M. Mazhar | |
dc.contributor.author | Kavlakoglu, Nail | |
dc.contributor.author | Inan, Basak Oguz | |
dc.contributor.author | Guden, Ege Can | |
dc.contributor.author | Ruzgar, Ummahan Rumeysa | |
dc.contributor.author | Aycicek, Ozlem Kurnaloglu | |
dc.contributor.author | Donmeze, Tolga | |
dc.date.accessioned | 2022-01-29T16:52:17Z | |
dc.date.available | 2022-01-29T16:52:17Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1781-782X | |
dc.identifier.uri | https://doi.org/10.5152/B-ENT.2021.20133 | |
dc.identifier.uri | http://hdl.handle.net/11446/4414 | |
dc.description.abstract | Objective: Coronavirus disease 2019 (COVID-19) is a new disease entity that appeared in late 2019. In this study, we aimed to determine the prevalence of loss of smell and/or taste among patients who tested positive for COVID-19 and identify demographic and clinical differences between patients with and without anosmia/dysgeusia. Methods: The study was performed in a referral center for COVID-19 in Istanbul, Turkey between the months of April and July 2020. The responses from a set of questions in regard to loss of sense of smell and/or taste were collected. None of these patients were exposed to any further examination or testing related to their senses of smell and/or taste. The data in regard to the patients being tested as well as their demographic information and co-morbidities associated with their condition were collected. Results: Twenty patients (10 male, 10 females, mean age 43.3 years) out of 86 patients (49 male, 37 female, median age 49.5 years), who tested positive for COVID-19, declared a loss of smell and/or taste. Nineteen patients (19/20, 95%) had a full recovery, and one (1/20, 5%) had partial recovery at the end of two weeks. Conclusion: Our results indicate that 23.3% of patients who tested positive with reverse transcription-polymerase chain reaction testing for COVID-19 had loss of sense of smell to a certain extent. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Aves | en_US |
dc.identifier.doi | 10.5152/B-ENT.2021.20133 | |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | dysgeusia | en_US |
dc.subject | olfaction disorders | en_US |
dc.subject | prevalence | en_US |
dc.subject | Dysfunction | en_US |
dc.title | The prevalence of anosmia among patients with COVID-19 in Istanbul, Turkey: A cross-sectional study | en_US |
dc.type | article | en_US |
dc.relation.journal | B-Ent | en_US |
dc.department | DBÜ | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.volume | 17 | en_US |
dc.identifier.startpage | 24 | en_US |
dc.identifier.endpage | 30 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.department-temp | [Celikoyar, M. Mazhar; Aktan, Erkan] Istanbul Florence Nightingale Hosp, Dept Otolaryngol Head & Neck Surg, Istanbul, Turkey; [Kavlakoglu, Nail] Istanbul Florence Nightingale Hosp, Dept Emergency Med, Istanbul, Turkey; [Inan, Basak Oguz] Sisli Florence Nightingale Hosp, Dept Internal Med, Istanbul, Turkey; [Guden, Ege Can; Ruzgar, Ummahan Rumeysa] Demiroglu Bilim Univ, Med Sch, Istanbul, Turkey; [Aycicek, Ozlem Kurnaloglu] Istanbul Florence Nightingale Hosp, Dept Infect Dis, Istanbul, Turkey; [Donmeze, Tolga] Sisli Florence Nightingale Hosp, Dept Emergency Med, Istanbul, Turkey | en_US |